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Previous studies conducted in our laboratory revealed that coconut kernel protein has a
significant cardioprotective effect on isoproterenol-induced myocardial infarction in rats. In
the present study, we explored the possible protective mechanism of coconut kernel protein
during acutemyocardial infarction. Coconut kernel protein (50mg/100 g)was administered to
Sprague-Dawley rats orally for 45 days. Isoproterenol (20 mg/100 g) was injected subcutane-
ously at an interval of 24 hours twice to induce myocardial infarction. Myocardial infarction
was confirmed by the abnormal activities of cardiac marker enzymes in serum. Activities of
antioxidant enzymes such as superoxide dismutase (SOD) and catalase were decreased
( p < 0.05) in the heart of isoproterenol-treated rats, whereas pretreatment with coconut
kernel protein increased ( p < 0.05) these activities. An improved antioxidant status in these
rats was further confirmed by the increased level of reduced glutathione and decreased level
of lipid peroxidation products. Nitric oxide synthase (NOS) activity in the heart and nitrite
level in blood were increased ( p < 0.05) in coconut kernel protein-treated rats administered
with isoproterenol compared to isoproterenol control rats. Coconut protein pretreatment
upregulated the expression of endothelial nitric oxide synthase (eNOS), whereas expressions
of nuclear factor-kappaB (NF-kB) and tumor necrosis factor-alpha (TNF-a) were down-
regulated in isoproterenol-treated rats. These findings suggest that the protective effects of
coconut kernel protein may be mediated in part through upregulation of nitric oxide pro-
duction, antioxidant mechanisms, and its ability to inhibit TNF-a and NF-kB activation.
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j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 1 ( 2 0 1 3 ) 3 2 5e3 3 13261. Introduction 2.2. Experimental animalsMyocardial infarction (MI) is one of the leading causes of death
worldwide. The pathophysiology of MI begins with plaque
formation in the coronary artery, which ruptures eventually,
causing thrombus formation and ischemia in the heart.
Experimental and clinical studies indicated that the pathology
of MI is mainly associated with oxidative stress [1]. The
resulting oxidative stress leads to free radical formation and
also triggers the inflammatory pathway that ultimately leads
to cell damage [2]. Therefore, therapeutic interventions that
improve antioxidant status may exert beneficial effects in
ischemic heart diseases. Pharmacological augmentation of
endogenous myocardial antioxidants has been identified as a
promising therapeutic approach in diseases associated with
increased oxidative stress such as MI [3]. Several studies have
demonstrated that NF-kB, an ubiquitous transcription factor,
activated by various stimuli such as reactive oxygen species
(ROS), hypoxia, and inflammatory cytokines such as tumor
necrosis TNF-a, is substantially involved in the progression of
cardiac remodeling [4,5]. Downregulation of TNF-a and NF-kB
may also attenuate cardiac remodeling and cardiac failure
after MI [6,7].
Recently, plant-based dietary agents that can minimize
cardiac damage during ischemia are gaining wide attention.
Our previous experiments showed that the major protein
fraction (globulins) isolated from coconut kernel protein (CKP)
possesses antidiabetic, antiperoxidative, and cardioprotective
effects [8,9]. Studies have suggested that L-arginine, the pre-
cursor of nitric oxide (NO), a vasodilatory hormone, can have a
positive effect during MI through the endothelial nitric oxide
synthase (eNOS) pathway [10]. Evidence suggests that reduced
NO availability may play an important role in the patho-
physiology both after experimental myocardial ischemia and
in patients with MI [11]. Inhibition of NO production results in
impaired endothelium-dependent vasodilation, reduces
myocardial neovascularization, and augments myocardial
remodeling [12].
Isoproterenol (ISO)-induced MI in rats is one of the
most widely used experimental models to study the
beneficial effects of many drugs on cardiac function.
Hence, ISO was chosen to induce experimental MI. Based
on these facts, the present study investigated the possible
role of CKP in modulating the antioxidant status and ex-
pressions of eNOS, TNF-a, and NF-kB against ISO-induced
acute MI.2. Methods
2.1. Drugs and chemicals
All chemicals used for the study, including ISO and TRI
reagent, were obtained from Sigma-Aldrich (St Louis, MO,
USA). Synthesis of cDNA and polymerase chain reaction
(PCR) were performed using commercial kits purchased
from Fermentas (Thermo Fisher Scientific Inc., Ottawa,
Canada). All other chemicals used were of the highest
analytical grade.Male albino Sprague-Dawley rats, weighing 150e200 g and
bred in our department’s animal house, were used for the
study. All animal care and procedures were performed ac-
cording to the guidelines of the Committee for the Purpose of
Control and Supervision of Experiments on Animals, India.
The entire experimental protocol was approved by the Insti-
tutional Animal Ethics Committee of the University of Kerala.
The animals were housed individually in polypropylene cages
placed in a roommaintained at 25  5 C, with a 12-hour light
and 12-hour dark cycle.
2.3. Isolation of CKP
The total globulin fraction was isolated from the kernel pro-
tein following a procedure described earlier [8].
2.4. Experimental protocols
The experimental animals were divided into four groups of six
rats each: Group I served as the normal control, Group II as the
ISO control, Group III as the CKP control, and Group IV as the
CKP-fed, ISO-administered experimental group.
All the animals were given standard rat chow (Sai Feeds,
Bangalore, India). CKP was administrated orally to rats of
Groups III and IV, at a dose of 50mg/100 g body weight. Calorie
intake was adjusted to be the same in all four groups by
supplementing casein at the same dose level as CKP to rats of
Groups I and II. The animals were fed the above diet and
distilled water ad libitum. Food consumption of individual rats
was recorded daily, and body weights were measured weekly.
Experiments were conducted for 45 days. At the end of the
experimental period, MI was induced in rats of Groups II and
IV by a subcutaneous injection of ISO at a dose of 20 mg/100 g
body weight, administered twice at an interval of 24 hours.
Rats that survived after the second dose of ISO injection were
deprived of food and subjected to euthanasia by means of an
intraperitoneal injection of thiopentone sodium (>40 mg/kg
body weight). The blood sample was collected and the heart
was removed, washed in ice-cold physiological saline, and
stored in a cold condition for various estimations.
2.5. Biochemical estimations
Serum glutamate oxaloacetate transaminase (SGOT) and
serum glutamate pyruvate transaminase (SGPT) were assayed
using the enzyme kit from CML Biotech (P) Ltd. (Kochi, India),
based on the method of Reitman and Frankel [13]. The activity
of creatine phosphokinase (CK-MB) was assayed by the
method of Olive modified by Rosalki [14], using an Enzopak
CK-MB kit from Reckon Diagnostics Pvt. Ltd. (Baroda, India).
Lactate dehydrogenase (LDH) was estimated using an enzyme
kit purchased from ERBA Diagnostics, Mumbai, Maharashtra,
India [15]. NOS activity in the heart was determined [16] and
the nitrite level in blood was estimated following the method
described by Green et al [17] SOD and catalase in the heart
tissue were assayed using the method described by Kakkar
et al [18] and that byMaehly and Chance [19], respectively. The
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procedure described by Patterson and Lazarow [20]. Thio-
barbituric acid reactive substances (TBARS) were estimated by
the assay method described by Ohkawa et al [21].
2.6. Isolation of total genomic RNA
Total genomic RNA was isolated from the heart using TRI re-
agent (Sigma-Aldrich) by the method described by Chomc-
zynski and Macke [22].
2.7. Synthesis of cDNA and reverse transcriptaseePCR
Synthesis of cDNA and PCR were performed as per the manu-
facturer’s instructions using the kit purchased fromFermentas.
The following primers were used: glyceraldehyde-3-phosphate
dehydrogenase (GAPDH): (forward) 50-CCT TCA TTG ACC TCA
ACT AC-30 and (reverse) 50-GGA AGG CCA TGC CAG TGA GC-30;
eNOS: (forward) 50-ATGGCGAAGCGTGTGAAG-30 and (reverse)
50-ATT GTG GCT CGG GTG GAT-30; NF-kB: (forward) 50-CCT AGC
TTT CTC TGA ACT GCA AA-30 and (reverse) 50-GGG TCA GAG
GCCAATAGAGA-30; andTNF-a: (forward) 50-AGTCTTCCAGCT
GGA GAA GG-30 and (reverse) 50-GCC ACT ACT TCA GCA TCT
CG-30. The reverse transcriptase-PCR products were electro-
phoresed on 1.5% agarose gel and visualized by staining with
ethidium bromide. The gels were subjected to densitometric
scanning (Gel Doc, Bio-Rad Laboratories, Hercules, CA, USA) to
determine the optical density of each and then normalized
against an internal control, GAPDH, using Quantity One imag-
ing software (Bio-Rad Laboratories, Hercules, CA, USA).
2.8. Histopathology
The heart tissues were dissected out rapidly, washed in saline,
and fixed by immersion in 10% formalin solution at room tem-
perature. For histological examinations, paraffin-embedded
tissue sections of the heart (5 mm) were stained with hematox-
ylineeosin [23]. The sections were then examined under light
microscope (Axioscope 2 plus, Zeiss, Thornwood, NY, USA) and
photographed (Zoom Browser EX, Canon, Tokyo, Japan).
2.9. Statistical analysis
Statistical analysis was performed by one-way analysis of
variance followed by Duncan’s multiple range test using SPSSTable 1 e Activities of LDH, creatine kinase, glutamate oxaloac
in serum.
Group LDH (IU/L) CK-MB (IU/L
I 244.49  22.30 480.83  43.87
II 768.53  70.11a 685.94  62.59
III 221.48  20.20 458.48  41.84
IV 589.88  53.82b 600.11  54.75
Data are expressed as mean  standard deviation of six rats. Significanc
LDH ¼ lactate dehydrogenase; CK-MB ¼ creatine phosphokinase; SGOT ¼
mate pyruvate transaminase.
a Values are significantly different from Group I.
b Values are significantly different from Group II.Statistics version 17.0.1 (SPSS Inc, Chicago, IL, USA). Results
were expressed as mean  standard deviation for six rats in
each group. A p value <0.05 was considered statistically
significant.3. Results
A marked rise in the activities of cardiac marker enzymes
such as LDH, CK-MB, SGOT, and SGPT was observed in the
serum of ISO-induced rats in comparison with normal control
rats. Rats pretreated with CKP showed a decreased activity of
these enzymes as compared to ISO-administered control rats
(Table 1). Activities of marker enzymes in Group III rats were
not significantly different from that in Group I rats. NOS ac-
tivity was decreased in rats treated with ISO alone compared
to normal rats, whereas the activity was increased in CKP-fed
rats on ISO administration (Table 2). Nitrite level in blood also
showed a similar trend. Activities of antioxidant enzymes
such as SOD and catalase increased in CKP-pretreated rats
compared to ISO control rats (Table 3). Level of reduced
glutathione, an endogenous nonenzymatic antioxidant, was
also increased in these rats. Peroxidative damage of lipids, as
evidenced by the thiobarbituric acid reactive substances
(TBARS), was low in CKP-pretreated rats (Fig. 1).
The expression of eNOS was upregulated in CKP-fed rats
administered with ISO in comparison with ISO control rats.
CKP-fed normal rats also showed an increased expression of
eNOS, but the increase was not significantly different from
normal rats (Fig. 2). NF-kB and TNF-a expressions were
increased in ISO control rats compared to normal rats. CKP-
fed rats, on ISO administration, showed a decrease in ex-
pressions of these inflammatory genes compared to ISO con-
trol rats.
3.1. Histopathological findings
Histopathological examination of the heart of control rats
showed normal morphology and architecture. The heart of
rats subjected to an ISO injection showed focal areas of
degeneration and necrosis, as compared to control rats.
Fragmented myocytes with eosinophilic and vacuolated
cytoplasm were also observed in these rats. The heart of ISO-
administered rats that were treated with CKP showed regen-
eration of myoblasts. Inflammation and necrosis were less inetate transaminase, and glutamate pyruvate transaminase
) SGOT (IU/L) SGPT (IU/L)
181.17  16.51 93.97  8.4
a 233.03  21.25a 197.28  17.95a
152.21  13.88 85.67  7.79
b 213.06  19.43b 176.27  16.07b
e is accepted at p < 0.05 between two groups.
serum glutamate oxaloacetate transaminase; SGPT ¼ serum gluta-
Table 2 e Effect of CKP on NOS activity in the heart and
nitrite level in blood.
Group NOS (unit/mg protein) Nitrite (mM/L)
I 0.093  0.007 12.62  1.15
II 0.073  0.006a 10.62  0.97a
III 0.096  0.007 12.91  1.18
IV 0.087  0.007b 12.16  1.39b
Data are expressed as mean  standard deviation of six rats. Sig-
nificance is accepted at p < 0.05 between two groups.
CKP ¼ coconut kernel protein; NOS ¼ nitric oxide synthase.
a Values are significantly different from Group I.
b Values are significantly different from Group II.
Table 3 e Effect of CKP on SOD, catalase activity, and
reduced GSH level in the heart.
Group SOD
(unit/mg
protein)
Catalase
(103 unit/mg
protein)
GSH
(mM/g
tissue)
I 49.86  4.54 8.97  0.80 1.93  0.16
II 21.06  1.90a 2.17  0.18a 1.25  0.10a
III 49.37  4.48 12.06  1.08 1.80  0.15
IV 38.58  3.51b 5.03  0.45b 1.60  0.14b
Data are expressed as mean  standard deviation of six rats. Sig-
nificance is accepted at p < 0.05 between two groups.
CKP¼ coconut kernel protein; GSH¼ glutathione; SOD¼ superoxide
dismutase.
a Values are significantly different from Group I.
b Values are significantly different from Group II.
Fig. 1 e Effect of CKP on TBARS level in the heart. The letter
‘a’ indicates that values are significantly different from
Group I and ‘b’ indicates that values are significantly
different from Group II. Data are expressed as mean ± SD of
six rats. Significance is accepted at p< 0.05 between two
groups. CKP [ coconut kernel protein; SD [ standard
deviation; TBARS [ thiobarbituric acid reactive
substances.
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pathological changes were graded and summarized (Table 4).4. Discussion
ISO is a synthetic catecholamine and b-adrenergic agonist
that, in large doses, is documented to induce MI due to the
generation of highly cytotoxic free radicals through its auto-
oxidation [12]. Inflammatory response and oxidative stress
have been recognized as possible mechanisms of ISO-induced
MI. Substantial evidence shows that ischemic tissue generates
oxygen-derived free radicals (oxygenmolecules containing an
odd number of electrons), making them chemically reactive
and often leading to chain reactions [24]. Studies carried out in
our laboratory indicate that CKP has hypolipidemic and car-
dioprotective effects [25,26]. We have reported that CKP is rich
in L-arginine [8]. The present study is intended to understand
the effect of CKP on the antioxidant status, and expressions of
eNOS and inflammatory mediators such as TNF-a and NF-kB
in rats induced with ISO.Fig. 2 e Effect of CKP on eNOS, NF-kB, and TNF-a gene
expressions on the heart tissue of normal and
experimental rats. The letter “a” indicates that are
significantly different from Group I and “b” indicates that
values are significantly different from Group II. Data are
expressed asmean ± SD of six rats. Significance is accepted
at p< 0.05 between two groups. CKP [ coconut kernel
protein; eNOS [ endothelial nitric oxide synthase;
GAPDH [ glyceraldehyde-3-phosphate dehydrogenase;
NF-kB [ nuclear factor-kappaB; SD [ standard deviation;
TNF-a [ tumor necrosis factor-alpha.
Fig. 3 e Photomicrograph showing histopathology of the heart (H&E 403). (A) Normal myocardium of control group. (B) ISO-
administered group showing diffused inflammation and extensive myocardial damage. (C) Normal myocardium of CKP-
treated group. (D) CKP-pretreated group on ISO administration showing almost normal myocardium. CKP[ coconut kernel
protein; FM [ fragmented myocytes; H&E [ hematoxylin and eosin; IMI [ inflammatory mononuclear infiltration;
ISO [ isoproterenol; MN [ myocardial necrosis.
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diagnostic marker enzymes such as CK-MB, LDH, SGOT, and
SGPT. Once metabolically damaged, the myocardium releases
its contents into the extracellular fluid. Increased activities of
these cardiac marker enzymes in serum of ISO-induced rats
confirm the onset of myocardial necrosis [27]. Similar results
were observed in the present study. An increase in the activ-
ities of marker enzymes in serum could be due to the leakage
of enzymes from the heart as a result of ISO-induced necrosis,
and the amount of enzymes that appear in serum is inTable 4 e Histopathological assessment of myocardium
in different experimental groupsa.
Group Necrosis Edema Inflammation
I e e e
II DDD DDD DDD
III e e e
IV D D D
a Relative pathological changes were graded as the histopatho-
logical score of each slide obtained from rats of four groups used in
the study and were ranked as follows: e ¼ no change, þ ¼ focal
change, þþ ¼ patchy change, and þþþ ¼massive change.proportion to the number of necrotic cells [28]. As evident
from the serum marker enzyme activity, pretreatment with
CKP attenuated these changes.
As already indicated, CKP is a good source of L-arginine
(17.8%) [8]. Recently, L-arginine supplementation has been
identified as a nutritional strategy for preventing and treating
MI. L-arginine is acted upon by NOS to produce NO, which is a
potent vasodilator [29]. Activity of NOS in the heart was
decreased significantly in the ISO-induced group, whereas
pretreatment with CKP resulted in a significant increase in the
activity of NOS. The higher level of nitrite in blood was due to
an increased production of NO, as evident from the increased
activity of NOS. Previous studies conducted using different
animal models demonstrated that L-arginine can increase NO
production, which reduces generation of superoxide anions
and prevents reduced expression of eNOS [30,31]. This sug-
gests the protective role of NO and eNOS in heart failure. In a
healthy heart, physiological amounts of NO may help sustain
cardiac inotropy. In heart failure, both upregulation [32] and
downregulation [33] of eNOS have been observed. Loss of
eNOS expression and NO production is observed in MI [12].
Overexpression of eNOS in cardiomyocytes was found to
improve cardiac function and reduce hypertrophy in heart
failure after MI [34]. NO derived from eNOS can decrease the
extent of myocardial hypertrophy, fibrosis, and myocyte loss
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through vasodilation.
Previous studies have shown that ISO-induced MI gen-
erates numerous free radicals and decreases the antioxi-
dant status of the myocardium, causing damage to the
cellular membranes through lipid peroxidation [2]. Similar
trends were observed in this study. An increased activity of
endogenous antioxidant enzymes such as SOD and catalase
was observed in CKP-treated rats on ISO administration
compared to the ISO control group. Moreover, a decrease in
lipid peroxidation and an increase in reduced glutathione
content were observed in CKP-treated rats. These results
showed that the oxidative stress during ISO administration
in rats was alleviated effectively by CKP, possibly due to the
presence of L-arginine. Reports suggest that L-arginine
supplementation relieves oxidative stress in experimental
MI [36]. The protective effect of L-arginine may be due to
antioxidant properties of eNOS-derived NO. NO is known to
inhibit ROS-mediated reactions, and it has been suggested
that the protective effects found in a variety of conditions
are due to the ability of NO to detoxify ROS such as O2
e, OH.,
and/or ferryl hemoprotein [37]. Recent studies carried out
by us indicate that CKP possesses antioxidant property and
the major factor responsible for the effect is L-arginine
[8,38].
Histopathological examination of myocardial tissue in
control and CKP-treated rats depicted clear integrity of the
myocardial cell membrane. No inflammatory cell infiltration
was seen in the heart of control and CKP-treated rats. In the
ISO-administered group, increased hyalinization, fragmenta-
tion of muscle fibers, and myocardial necrosis were observed.
Pretreatment with CKP demonstrated reversal of focal lesions,
fragmentation of muscle fibers, and retrogressive lesions with
hyaline necrosis in the ISO-treated group, confirming further
the cardioprotective activity of CKP.
Several studies support the theory that inflammation plays
an important role in cardiovascular diseases including MI
[39,40]. NF-kB is a prime target for ROS [4]. Activation of NF-kB
appears to play a significant role in the pathophysiology of
endothelial dysfunction, unstable angina pectoris, acute MI,
and heart failure [41]. Thus, suppression of NF-kB activity can
be a potential mechanism for regulating inflammatory re-
sponses [42]. Upregulation of TNF-a is also observed during
ISO-induced MI [43]. Many studies have reported that ISO
administration stimulates the proinflammatory cytokine
TNF-a [44,45]. Our study showed that CKP treatment down-
regulates expressions of NF-kB and TNF-a in ISO-induced rats,
which may be due to a decrease in oxidative stress stimulus
via NO-mediated protection. This observation suggests that
CKP is effective in preventing inflammatory responses that
are triggered by ISO-induced MI.
The protective effect of CKP seems to be mediated mainly
through its ability to modulate the nitric oxide pathway, and
inhibit mRNA expressions of NF-kB and TNF-a. In conclusion,
these results suggest that dietary supplementation of CKP
may have a greater significance in reducing the extent of
oxidative stress and inflammatory responses associated with
MI. Therefore, CKPmay be included as a protein addendum for
the development of a cardiotonic nutraceutical or functional
food.r e f e r e n c e s
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